PerkinElmer, a New York-listed medical technology company, has acquired peer VisEn Medical from its corporate venturing backers for an undisclosed sum.
Although VisEn was formed in 2000, Germany-based industrial conglomerate Siemens made the first public strategic investment in the group in 2003. This was later followed by $16m in disclosed venture investments between August 2005 and April 2008 when Merck Capital Ventures, the $100m corporate venturing fund of US-based Merck & Co, co-led a $5m series B extension.
News provider PEHub said VisEn had in total raised $30m.
Merck was unavailable to comment about its Capital Ventures fund, which was launched in November 2000 and effectively wound up in July 2008 when Per Lofberg, president of the strategic investment subsidiary, left.